The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; 6 of the 21 sources its claims cite were checked for support.
The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy
Open accessAbstract
Thirty-year % increase of adults with hypertension in the European/ Americas and South-East Asia/ Western Pacific (WHO region). Create using the data from: World Health Organization. Global report on hypertension: the race against a silent killer. Geneva, Switzerland: 2023.
Overview
CoChat Summary
TL;DR
This commentary summarizes the WHO 2023 Global report on hypertension, highlighting the global and especially Asian burden of uncontrolled hypertension and the report's recommended strategies. It advocates a home blood pressure-centered approach, salt reduction, and multidisciplinary team care via the HEARTS technical package.
Key findings
- Only 54% of adults with hypertension are diagnosed, 42% receive treatment, and just 21% have their hypertension controlled; global uncontrolled hypertension prevalence fell slightly to 26% in 2019 (down 3 percentage points from 2010), still above the voluntary global target of 21%.
- Regional burden is shifting: hypertensive adults in the WHO Western Pacific region rose from 144 million (1990) to 346 million (2019), and prevalence increased in the Western Pacific (24% to 28%) and Southeast Asia (29% to 32%), while it decreased in the WHO European region.
- Over 30 years, adult hypertension patients increased 41% in the WHO European/Americas regions versus 144% in the WHO South-East Asia/Western Pacific regions.
- Excessive salt intake (≥5 g/day) contributed to 2 million cardiovascular deaths in 2019 (GBD 2019); each 1-g increment in estimated sodium excretion was associated with a 2.11 mm Hg systolic BP increase. A Japanese nutritionist-guided salt-restriction study reduced salt intake by an additional 1.8 g/day versus conventional education.
Methods
- Design: narrative commentary/opinion piece ("Graphical Opinion") synthesizing the WHO 2023 Global report on hypertension and related literature; no primary data collection.
- Data: cited statistics from the WHO report, GBD 2019, NCD Risk Factor Collaboration, and referenced trials (STEP, SPRINT, BPLTTC) and studies (e.g., Finn-Home, Mente et al., Nakano et al.).
- Analysis: descriptive synthesis of report findings and cited evidence; no formal statistical analysis performed.
Limitations
- Not stated in the paper: the authors declare no competing interests but do not list study limitations.
- Evident from the text: this is a short commentary rather than an original study, so it relies entirely on secondary sources and provides no new empirical data or systematic review methodology; several figures are reprinted from other sources (Kario et al. [3], [9]).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
6 Valid · 0 Not valid · 13 Not checked · 6 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For strict management of hypertension control, home BP measurement has increasingly emerged as a key metric, supported by research findings that show a stronger association with cardiovascular risk factors compared to office BP [4,5].”
§ The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy > Home BP centered approach for eradicating uncontrolled hypertension
What the sources say
- Partly supportedcites [4] Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010;55:1346–51. sourceExperimental — accuracy not yet measured
The Abstract and “BP and CV Risk” section report that home BP predicted cardiovascular events more strongly than office BP, supporting the comparison. But the study treated other cardiovascular risk factors as adjustment variables; it did not establish a stronger association between home BP and those risk factors. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [5] Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A large prospective, epidemiologic study found a systolic blood pressure increase of 2.11 mm Hg for each 1-g increment in estimated sodium excretion [11].”
§ The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy > Tackling high salt intake
What the sources say
- Supportedcites [11] Mente A, O’Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11. source
The Results (p. 1) report a regression-estimated 2.11 mm Hg increment in systolic blood pressure for each 1-g increment in estimated sodium excretion. The Methods (p. 1) describe a study of 102,216 adults from 18 countries. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It gains endorsement more and more from recent guidelines and consensus documents [6,7].”
§ The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy > Home BP centered approach for eradicating uncontrolled hypertension
What the sources say
- Not checked — no full text of the sourcecites [6] Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;41:1874–2071. source
- Supportedcites [7] Kario K, Park S, Chia YC, Sukonthasarn A, Turana Y, Shin J, et al. 2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network. J Clin Hypertens. 2020;22:351–62. source
The cited 2020 HOPE Asia Network consensus (Section 3, 'HBPM is an essential component of any hypertension management plan because home BP has been shown to provide better prognostic information than office BP measurements') is itself a recent consensus document that endorses home blood pressure measurement, with Class I/IIa recommendations for its use in diagnosis, treatment targeting (<135/85 mm Hg) and risk stratification (Table 3, Section 3). It therefore exemplifies the endorsement the citing sentence attributes to 'recent guidelines and consensus documents'. The document does not itself assert an increasing temporal trend, and its item 7 only says HBPM 'may be incorporated into local clinical hypertension guidelines' (Class IIa, level C), but the overall stance is clear endorsement. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It's important to highlight that Asians generally seems to experience greater benefits (reduced the onset of cardiovascular disease, stroke, coronary artery disease and heart failure) from strict BP control compared to Western populations (Fig. 1) [3].”
§ The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy > Home BP centered approach for eradicating uncontrolled hypertension
What the sources say
- Partly supportedcites [3] Kario K, Mogi M, Hoshide S. Latest hypertension research to inform clinical practice in Asia. Hypertens Res. 2022;45:555–72. sourceExperimental — accuracy not yet measured
The STEP study section reports greater cardiovascular risk reduction with intensive blood-pressure lowering in older Chinese patients than in the Western comparator studies. It says this may indicate greater benefits in elderly Asian populations, but calls for further study; it does not establish the claim for Asians generally. (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
In the paper
“The report emphasizes potassium-enriched salt substitutes as an affordable strategy [1].”
§ The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy > Tackling high salt intake
What the sources say
- Not matchedcites [1] World Health Organization. Global report on hypertension: the race against a silent killer. Geneva, Switzerland: World Health Organization; 2023, p. 1–276.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
1 more claim
Create a free account to see all 25 claims and to verify the 1 reference still open.
- Borderline: one of the tests for a substantial claim is unclear. 1
- Probably not a substantial claim. 12
- It may state two separate claims as one. 8
Citations
Cites
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., Gregg, E. W., Bennett, J. E., Solomon, B., Singleton, R. K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01330-1 · Cited by 3,902
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Association of Urinary Sodium and Potassium Excretion with Blood Pressure
Mente, A., O'Donnell, M. J., Rangarajan, S., McQueen, M. J., Poirier, P., Wielgosz, A., Morrison, H., Li, W., Wang, X., Di, C., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311989 · Cited by 858
Bobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842
Niiranen, T. J., Hänninen, M.-R., Johansson, J., Reunanen, A., & Jula, A. M. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149336 · Cited by 390
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network
Kario, K., Park, S., Chia, Y., Sukonthasarn, A., Turana, Y., Shin, J., Chen, C., Buranakitjaroen, P., Divinagracia, R., Nailes, J., et al. (2020) · The Journal of Clinical Hypertension · doi:10.1111/jch.13751 · Cited by 76
Self-citationNiiranen, T., Hänninen, M.-R. A., Johansson, J. K., Reunanen, A., & Jula, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.09.041 · Cited by 57
Bobrie, G., Châtellier, G., & Genès, N. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.04.039 · Cited by 42
Cited by
Global burden of metabolic diseases, 1990–2021
Zhang, H., Zhou, X.-D., Shapiro, M. D., Lip, G. Y. H., Tilg, H., Valenti, L., Somers, V. K., Byrne, C. D., Targher, G., Yang, W., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155999 · Cited by 368
Hypertension: A Continuing Public Healthcare Issue
Goorani, S., Zangene, S., & Imig, J. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010123 · Cited by 205
Hisamatsu, T., Kogure, M., Tabara, Y., Hozawa, A., Sakima, A., Tsuchihashi, T., Yoshita, K., Hayabuchi, H., Node, K., Takemi, Y., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01861-x · Cited by 48
Kim, H. C., Lee, H., Lee, H., Ahn, S. V., Lee, J., Cheon, D. Y., Jhee, J. H., Yoon, M., Shin, M., Heo, J., et al. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e11 · Cited by 56
Młynarska, E., Wasiak, J., Gajewska, A., Bilińska, A., Steć, G., Jasińska, J., Rysz, J., & Franczyk, B. (2024) · Nutrients · doi:10.3390/nu16234079 · Cited by 39
Metadata
- Authors
- Kario, K., Okura, A., Hoshide, S., & Mogi, M.
- Affiliations
- Jichi Medical University (JP)
- Ehime University (JP)
- Corresponding author
- Kario, Kazuomi
- Venue
- Hypertension Research
- Published
- 2024-03-05
- Volume
- 47
- Issue
- 5
- Pages
- 1099-1102
- ISSN
- 0916-9636 (ISSN-L)
- 1348-4214
- OpenAlex
- W4392469446
- Cited by
- 425
- References
- 13
- Citations by year
- 2026: 181 · 2025: 196 · 2024: 47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Hypertension Research (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- hypertension, hypertension prevalence, global burden of disease, adults
- MeSH terms
- Antihypertensive Agents, Humans, Hypertension, Global Health, World Health Organization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. https://app.cochat.ai/papers/10.1038/s41440-024-01622-w
- The paper
- Kario, K., Okura, A., Hoshide, S., & Mogi, M. (2024). The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertension Research. https://doi.org/10.1038/s41440-024-01622-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


![Fig. 2 Home blood pressure-centered approach for personalized anticipation medicine from digital health to medical practice. BP blood pressure. Source: Kario et al. [9]. Reprinted with permission](https://figures.cochat.ai/paper-figures/d62f36fa68e444e88699ae0ff73011d6/the-who-global-report-2023-on-hypertension-warning-the-emerging-hypertension-figure-2.png)